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INTRODUCTION 
Lichen Planus is one of the most itchy dermatoses, worldwide in 
distribution, without racial, climatic or sex predilection. It is relatively 
common disease of the skin, also affecting the mucous membranes, nails 
& hair. 
Lichen planus produces intolerable itching which may interfere 
with sleep. The cosmetically unacceptable hyperpigmentation and the 
hypertrophic lesions produced in the course of the disease, make it a 
troublesome one. 
The natural course of the disease without treatment is usually 
prolonged. Its chronicity is associated with certain morphological types. 
Spontaneous resolution is not invariable and sometimes, the damage 
produced is permanent. 
It is considered a cell-mediated reaction to some unknown antigen 
and various modalities of treatment are available . 
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REVIEW OF LITERATURE 
 
DEFINITION 
Lichen planus is a distinctive cutaneous entity with prototypic 
lichenoid papules that show distinctive colour, morphology and 
microscopic features, develop in typical locations and manifest 
characteristic patterns of evolution.  
TERMINOLOGY  
The appearance of lichen planus (Greek leichen ‘tree moss’, Latin 
planus ‘flat’) & lichenoid dermatoses has been likened to the scurfy, 
finely furrowed, dry excrescences of the symbiotic vegetation known as 
lichen. 
The term ‘lichenoid’ is used by clinicians to describe a flat topped, 
shiny, papular eruption resembling lichen planus or by histopathologists 
to describe a type of tissue reaction consisting principally of basal cell 
liquefaction and a band-like inflammatory infiltrate in the papillary dermis2. 
Lichenoid eruptions occur due to drugs, contact with colour 
developers and in infection with Treponema pallidum3.  
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HISTORICAL ASPECTS 
1. William James Erasmus Wilson in 1869 delineated and 
named the condition lichen planus4. 
2. Hebra had described it earlier as lichen ruber planus. 
3. 1895 – Wickham described the characteristic striae5 
4. 1909 – Darrier elaborated the histopathological findings  
5. 1919 – Graham little reported scalp and follicular 
involvement  
6. 1973 – Pinkus defined lichenoid tissue reaction2.  
AETIOPATHOGENESIS 
It is evident that immunological mechanisms almost certainly 
mediate the development of lichen planus6. No consistent alterations in 
immunoglobulins have been shown in lichen planus and humoral 
immunity is most likely a secondary response in immunopathogenesis. 
Cell mediated immunity plays a major role in triggering clinical 
expression of the disease. Both CD4+ & CD8+ T cells are found in 
lesional skin in dermis while CD8 + T cells infiltrate epidermis. 
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Progression of disease leads to preferential accumulation of CD8 + 
T cells. The CD8+ cells & CD45 + RO cells are responsible for the 
development of apoptosis in LP. 
The epithelial lymphocyte interaction can be divided into 3 stages 
1. LICHEN PLANUS – SPECIFIC ANTIGENIC RECOGNITION 
2. CYTOTOXIC LYMPHOCYTE ACTIVATION  
3. KERATINOCYTE APOPTOSIS 
1. LICHEN PLANUS SPECIFIC ANTIGENIC RECOGNITION 
a. CD8+ lesional T cells recognize an LP - specific Antigen which 
is presented by Langerhans cells or epidermal keratinocytes in 
association  with MHC class I molecules. CDla+ Langerhans 
cells & factor XIIIa+ cells are increased in LP9. 
b. The nature of antigen is unknown 
c. Antigen could be an 
i) Autoreactive peptide 
ii) Exogenous Ag – altered protein / drug / contact allergen / 
viral or  infectious agent 
iii) unidentified immunogenic target 
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Low grade chronic exposure to mercury, gold etc may stimulate a  
lymphocyte reaction that manifests as lichen planus. 
The role of infection though provocative, no conclusive evidence 
has linked LP to infections like HCV,10,23,24 syphilis, HSV type 2, HIV 
amoebiasis11, chronic bladder infections, H.Pylori12 , HPV, HBV 
infections13 & vaccination14. 
2. CYTOTOXIC LYMPHOCYTE ACTIVATION  
a) The CD8+ T cells undergo clonal expansion in tissues. 
b) Production of IL-2,, IL-4, IL-10, IFNγ TNF-α & TGF-β by 
T lymphocytes. 
IFNγ upregulates MHC class II expression & expression of ICAM-
1 and VCAM-1 by basal keratinocytes, Langerhans cells, thus enhancing 
their interactions with lymphocytes   
c) Keratinocytes produces cytokines like  IL-1β, IL-4, IL-6, 
GM-CSF and TNF - α17. 
d) RANTES19 (Regulated upon activation normal T-cell 
expressed and secreted) secreted by T cells may trigger mast 
cell degranulation with consequent release of TNF-α which 
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in turn up regulates lesional T-cell13 RANTES & MMP – 9 
secretion. 
e) Mast cell degranulation and T-cell secretion of MMP-920 
may contribute to basement membrane disruption, enabling 
T cell migration into epidermis. 
3.   KERATINOCYTE APOPTOSIS 
Possible mechanisms21 include 
a) T-cell secreted TNF-α binding to TNF-α R1 receptor on 
keratinocyte surface. 
b) T-cell surface CD95L (fas ligand) binding CD95 (fas) on 
keratinocyte. 
 c) T-cell secreted matrix metalloproteinase-9 (MMP-9) disrupts 
epithelial basement membrane blocking cell survival signals 
to keratinocytes. All these mechanisms can activate 
keratinocyte caspase cascade resulting in apoptosis.  
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GENETICS  
Fewer than 100 cases of familial LP25 have been reported. 
LP has also been reported in monozygotic twins26. Familial forms 
tend to be more protracted and severe and present in erosive, linear or 
ulcerative patterns or with atypical features affecting young adults and 
children. 
HLA27 haplotypes associated with familial LP – HLA B7, 
HLAB18, HLACW8. 
HLA haplotypes28 associated with non-familial LP – HLA A3, - 
A5, -A28, - B8, - B16, - BW35  
HLA B8-common with oral LP as sole manifestation 
HLABW35 – strongly associated with cutaneous 
EPIDEMIOLOGY 
Age Incidence 
In India lichen planus is more prevalent in the age group of 20-40 
yrs, 29,30,31 while in the west, it is more prevalent between 30-60 yrs, Both 
oral & cutaneous lichen planus have rarely been reported in childhood32. 
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Sex Incidence  
Although there is no particular sexual predilection, some studies 
have indicated a male preponderance30 and few others, a female 
preponderance31. 
GEOGRAPHICAL INCIDENCE 
Worldwide in distribution No overt racial predisposition. 
An incidence of 0.38% of dermatology outpatients has been 
reported from a study in India.33   
CLINIAL FEATURES 
Lichen planus is characterized by shiny, violaceous, flat topped 
polygonal papules which retain the skin lines and which vary in size from 
pinpoint to a centimetre or more across, they may be closely aggregated 
or widely dispersed. 
WICKHAM’S STRIAE34 
Fine whitish puncta or reticulate networks, considered to be highly 
characteristic, more easily observed after applying oil, xylene or water 
and visualising the lesions with a magnifying lens or a handheld 
dermatoscope. It is due to localized thickening of stratum granulosum 
although a focal increase in the activity of lichen planus may account for it.  
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KOEBNERIZATION 
In the acute, evolving stage of the disease, scratching, injury or 
trauma may induce an isomorphic response37. 
According to Brocq, methodical grattage produces turgescence of 
papules and eventually subepidermal purpura.  
SITES AFFECTED 
LP can affect any part of the body, but the extremities are involved 
usually symmetrically. 
The volar aspect of wrist, flexural areas of arms, legs, lumbar 
region, around the ankles are often involved. Lower limbs have been 
found to be most commonly involved in many Indian studies29. 
(Pillsburyetal, 1956; Ormbsby & Montgomery, 1954; Sutton, 1956). 
The ankles and shins are the commonest sites for hypertrophic 
lesions. Face is usually spared and palmoplantar involvement is unusual. 
Inverse lichen planus affects axillae, groin and inframammary areas. All 
the mucosal sites may be affected. 
 10
NATURAL HISTORY & EVOLUTION 
Although a few cases evolve rapidly and clear within a few weeks, 
the onset is usually insidious. In most cases, the papules eventually flatten 
over a  few months, often to be replaced by an area of pigmentation that 
retains the shape of the papule & persists for months or years. 
In a third of cases, further spread of lesions occurs. In generalized 
disease, the eruption often spreads within 1-4 months from onset.  
One Indian study reported the duration to be from 1 month to 7 
years33.  (Bhattacharya M etal). 
Another Indian study has found the duration to vary from 5 days to 
30 yrs (Kachwa D et al). 
In the majority of patients the average duration is about 15 months. 
Oral & hypertrophic lesions tend to have a chronic course. Relapse occurs 
in less than 20% patients36. 
SYMPTOMATOLOGY 
Itching is a fairly consistent feature of lichen planus29,31. It may 
vary from mild irritation to severe itching. A few cases are asymptomatic.  
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Hypertrophic lesions itch severely. Paradoxically, there is seldom 
evidence of scratching, as the patient rubs rather than scratches to gain 
relief. 
Oral involvement can present with discomfort, stinging or pain 
especially on intake of hot foods and drinks. Ulcerated lesions are 
especially painful.  
ROLE OF VARIOUS PROPOSED AETIOLOGICAL FACTORS IN 
LICHEN PLANUS 
LP as a viral infection.; Thyresson  and Moberger (1957) 
considered lichen planus as a skin manifestation of a dermatotropic virus. 
Virus-like particles had been identified in basal layer by some. But later, 
studies with electron microscopy by Tuffanelli in 1976 did not show any 
viral particles. 
Several studies have analysed the association of liver disease and 
lichen planus. A few have reported a positive association. 40 41, but many 
others have demonstrated no association42,43. The association of 
carbohydrate intolerance and frank diabetes mellitus with lichen planus 
has also not yet been proved beyond doubt. However, a few studies have 
indicated a positive association.44,45 Grinspar etal in 1965 reported an 
incidence of 6% of LP in patients with  carbohydrate intolerance. 
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Recently many studies have reported a strong association of 
Hepatitis B vaccination and lichen planus in children.13,14. The HBsAg 
component of vaccine might be responsible (Saywell CA etal).  
The LP lesions develop on an average 40 days after vaccination47. 
(Rybojad M et al)    
No well established association has been documented between 
emotional stress46, tobacco use, oral or gastrointestinal candidiasis, or 
carbohydrate intolerance and development of lichen planus. 
CLINICAL VARIANTS 
1. According to configuration of lesions  
a)  Annular 
b)  Linear 
2. According to Morphology 
 a) Hypertrophic LP 
 b)  Atrophic LP   
 c)  Vesiculobullous 
 d)  Erosive & ulcerative 
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 e)  Follicular 
 f)  Actinic 
 g)  Lichen planus pigmentosus  
 h)  Other rare forms – perforating, guttate etc 
3.  According to site of involvement  
 a) Palms & soles 
 b)  Mucosa 
 c)  Nails 
 d)  Scalp 
ANNULAR LICHEN PLANUS 
Arcuate groupings of individual papules that develop rings or 
peripheral extension of clustered papules with central clearing. They may 
be widely scattered and usually have a very narrow rim of activity and a 
depressed slightly atrophic centre (annular atrophic lichen planus) Site : 
More common on the penis . 
Actinic LP is frequently annular. Also has predilection for 
intertriginous areas like axilla, groin. Annular atrophic lichen planus is 
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frequently chronic. The central atrophy is due to elastolysis by the 
infiltrating inflammatory cells.  
Another form of annular lichen planus occurs when larger lesions 
reach 2 to 3 cm in diameter and become hyperpigmented with a raised 
outer rim .This may occur on the trunk or extremities. 
LINEAR LICHEN PLANUS 
a) Linear lesions as part of koebnerization. 
b) Isolated linear lesions, made of small papules in close 
opposition are rare. More common in childhood. 
c) Long narrow lesions along the whole length of a limb – 
overlap with lichenoid epidermal nevus (Bronstein MH et al, 
1989) 
d) Multiple linear LP along Blaschko’s lines (Kabbash C et al, 
2002) has been reported. 
e) Multiple linear LP in a HIV patient (Ruiz Villavede R et al, 
2002). 
f) Segmental LP co-localized with vitiligo in a case (Sardana K 
et al , 2002) 
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g) Zosteriform LP has also been described. (Khanna N et al, 
1996).  
h)    Lichen planus can develop at the site of healed zoster. 
HYPERTROPHIC LICHEN PLANUS (LICHEN PLANUS 
VERRUCOSUS) 
1. Usually occurs on the extremities, around the ankle, shins & 
 interphalangeal joints. 
2. Most  pruritic variant 
3. Lesions are thickened, elevated, purplish or reddish brown in 
colour & hyperkeratotic 
4. Chronic course 
5. Chronic venous insufficiency is frequently present 
6. Heals with scarring, atrophy, hyper or hypopigmentation.  
7. Multiple cutaneous horns, keratoacanthoma and malignant 
transformation has been reported. 
8. Photodistributed hypertrophic lichen planus has been 
described in a patient with AIDS. 
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ATROPHIC LICHEN PLANUS 
1. Few well demarcated white-bluish papules or plaques with 
central superficial atrophy. 
2. Resolved hypertrophic and annular lesions present as 
atrophic lichen planus. 
3. Usually in the lower extremities or trunk. 
VESICULO BULLOUS LICHEN PLANUS 
a) Development of vesicles and bullae from the papules of 
lichen planus and  rarely from normal appearing skin 
b) The eruption is only of short duration and resolves in a few 
months. 
c) Can be differentiated from LP pemphigoides by 
immunofluorescence 
EROSIVE & ULCERATIVE LICHEN PLANUS 
a) Chronic painful bullae and ulcerations of the feet with 
typical lesions of  nails, skin and mucosa. 
b) Permanant loss of toe nails and cicatricial alopecia of the 
scalp are common. 
 17
c) Squamous cell carcinoma may develop. 
d) Severe cases of oral lichen planus can present with erosions 
& ulcers extending to the posterior pharynx, larynx and 
rarely, even the oesophagus. 
FOLLICULAR LICHEN PLANUS 
a) May occur alone or in association with other forms of 
cutaneous or mucosal LP 
b) Synonyms : lichen planus follicularis, peripilaris, acuminatus 
c) Individual keratotic follicular papules and studded plaques 
are seen.  
d) Sites affected – Trunk and medial aspect of proximal 
extremities. 
e) Scarring alopecia of the scalp can occur 
f) Variants –  
 1.  Graham Little Piccardi Lassueur Syndrome  
 2. Pseudopelade of Brocq 
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 3.  LP follicularis tumidus with oval pseudotumoral 
 plaques of mastoid area  
4. Postmenopausal frontal fibrosing alopecia 
g) Fountain sign – Injection of saline around follicle leads to 
discharge of saline through  follicular orifice like fountain. 
ACTINIC LICHEN PLANUS 
(Lichen planus subtropicus, summer time actinic lichenoid 
eruption, lichenoid melanodermatosis) common in  
a) Middle East ,East Africa and India 
b) Common in children and teenagers64. Mean age – 14 yrs   
c) Incidence in various Indian studies has varied from 4 to 14% 
d) 3 clinical types 
 a)  Annular – commonest 
 b)  Pigmented – Melasma – like65 
 c)  Dyschromic 
e) Sites – exposed areas of face, dorsal hands, arms, nape of the neck. 
f) Pruritus & scaling are minimal  
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LICHEN PLANUS PIGMENTOSUS  
a) Slate gray to brownish black macules over sun exposed areas 
and occasionally over intertriginous areas67. 
b) The pigmentation may be diffuse, reticular, blotchy or 
perifollicular. 
c) Mucosa, palms & soles are usually not involved. 
d) May or may not be associated with LP papules 
e) Middle East & India 
OTHER RARE FORMS 
1. Perforating variant – Transepidermal elimination of lichen 
planus like inflammatory tissue is observed 
2. Exfoliative & exanthematous form. 
3. Invisible de Gougerot – lesions are not perceptible with 
visible light but become apparent with WOOD’S LAMP 
examination. 
4. Guttate LP – widely scattered, discrete lesions, may be small 
or large. 
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5. Acute and subacute LP with confluence of lesions – may 
simulate PR in the early phase and eczema later. Drug 
induced lichenoid eruptions may  present in this fashion. 
LP OF PALMS AND SOLES68 
1. It is rare, may present diagnostic difficulty if present as an 
isolated finding. 
2. Pruritus may or may not be present 
3. Lacks the characteristic colour & shape of lesions elsewhere. 
4. Inner plantar arch, lateral aspect of fingers & palms are 
involved. 
5. Erythematous scaly plaques or yellowish69 hyperkeratotic 
papules may be seen.  
MUCOSAL LICHEN PLANUS 
ORAL MUCOSA – lesions may be confined to the mouth or be 
accompanied by skin lesions & account for 15% all cases70. 
The types of lesions include Reticular, Atrophic, Papular, Plaques, 
Erosive & Bullous  forms. 
Reticular LP is the most frequent type71. 
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The lesions are bilateraal72 & involve the lips, tongue, buccal 
mucosa & gingivae. 
They are often symptomless but may cause soreness & pain 
particularly in erosive type. 
GENITAL INVOLVEMENT 
Males : Classical red-purple papules, patches & plaques and 
annular lesions can occur over penile shaft, glans, prepuce, scrotum, 
groins & perianal skin. Phimosis can occur. The lesions may be localized 
to anogenital or be part of generalized involvement. Erosive form can 
occur as peno-gingival syndrome73. Usually, anogenital LP is self-
limiting.  
Females : Vulval involvement74 may occur in isolation or it may be 
part of generalized outbreak in 20% of cases or associated with oral 
involvement alone. The clinical lesions include papules, white or annular 
plaques and erosions with or without lacy borders. Erosive lesions may 
involve  labia minora, clitoris & clitoral hood. Other clinical forms 
include pigmented &flexural LP, vulvovaginal gingival LP75 & lichen 
plano pilaris of vulva. 
Erosive forms can present with dyspareunia, scarring & loss of 
normal vulvar architecture. 
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Other Mucosae which can be involved are oesophagus, 
conjunctiva, urethra, anus, nose & larynx. 
Oesophagus – dysphagia & strictures  
Anus – leucokeratosis, hyperkeratosis, fissuring & erosions, 
conjunctiva – cicatricial conjunctivitis. 
LP OF NAILS  
a) Nail involvement77 occurs in 10% of cases of widespread LP. 
b) Isolated involvement is rare, often followed by clinical 
involvement elsewhere. 
c) 5th & 6th decades are usually affected, long term permanent 
damage is rare. 
d) Thinning, longitudinal ridging, linear depressions & 
onychoschizia are the most common findings. 
e) Other findings of nail matrix involvement are onychorhexis, 
longitudinal  melanonychia78, leukonychia, pterygium & loss 
of nails 
f) Nail bed involvement can lead to onycholysis & subungual 
hyperkeratosis 
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g) Bluish discoloration of proximal nail fold, yellow-nail 
syndrome like features can also occur 
h) ‘PUPTENT’ SIGN – Nail bed involvement that elevates the 
nail plate &  may cause longitudinal splitting 
g) Nail involvement in childhood76 is rare. Twenty nail 
dystrophy may occur as an isolated finding. 
LP OF SCALP 
1. Uni or multifocal areas of scarring alopecia occur. 
2. Middle aged women are usually affected 
3. Recent scalp lesions may show violaceous papules ,erythema 
and scaling .These papules are replaced quickly by follicular 
plugs and scarring. Eventually the plugs are shed from the 
scarred area which remains white ,smooth and 
atrophic.Follicular orifices are absent in the area of alopecia.  
If the patch is extending , horny plugs may still be present in 
follicles around its margins and the hair pull test will be 
positive at the margins. 
4.   Patients usually present with pseudopelade like patches of 
scarring that are non-specific. 
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5. Scalp may be involved alone or associated in 50% of cases with 
a. Bullous lichen planus with shedding of nails. 
b. bullous lesions with typical lichen planus lesions of 
skin and mucosa. 
c. Lichen planopilaris of trunk 
6. The variants of cicatricial alopecia due to lichen planus are 
lichenplanopilaris79, Graham Little Piccardi Lassueur 
syndrome, post menopausal frontal fibrosing alopecia80. 
lichen planus follicularis tumidus, lichen planoporitis and 
pseudopelade of Brocq.  
7. Frontal fibrosing alopecia- resembles  androgenetic alopecia 
with frontal recession ,but on close inspection, loss of 
follicular orifices and perifollicular erythema with 
hyperkeratosis at the marginal hairline.Frontal hairline 
recedes in a straight line rather than bitemporally. 
8. Lichen planoporitis - lichenoid reaction centered over 
acrosyringium and eccrine ducts entering the epidermis. 
9. Natural history - slow progression over many years.No 
effective treatment available. 
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INVERSE LICHEN PLANUS 
Rare Red-brown discrete papules and nodules. Flexural areas like 
axilla, inframammary, groin are involved. 
HISTOPATHOLOGY 
Typical papules show the following features81 
a. Compact orthokeratosis 
b. Wedge-shaped hypergranulosis  
c. Irregular acanthosis 
d. Vacuolar alteration of basal layer 
e. Band-like dermal lymphocytic infiltrate in close 
approximation to the dermis. 
WICKHAM’S STRIAE  
Focal increase in thickness of granular layer and infiltrate.  
Rete ridges show irregular lengthening with some showing 
flattening & pointed ends – ‘SAW TOOTHING’ 
Dermal papilla between retiridges – dome shaped 
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COLLOID BODIES82 – Hyaline, cytoid, or civatte or 
Sabaurod’s bodies 
20µ in diameter homogenous, easinophilic PAS positive, diastase 
resistant. 
Present in the lower epidermis and upper dermis formed by 
filamentous degeneration of damaged keratinocyes. 
Colloid bodies are best seen with PAS stain but can be recognized 
with routine H&E stain. Colloid bodies occur most frequently in the early 
, well developed lesions and do not extend throughout the length of the 
section ,so should be searched for.                     
MAX JOSEPH SPACE83 - Focal separation of epidermis from 
dermis 
BAND-LIKE Inflammatory infiltrate47 – sharply demarcated 
at its lower border. 
Composed entirely of lymphocytes intermingled with macrophages 
and few eosinophils and / or plasma cells. 
Pigmentary incontinence with dermal melanophages is 
characteristic 
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HYPERTROPHIC LP84  
• Considerable acanthosis, papillomatosis, hypergranulosis 
and hyperkeratosis.  
• Interface vacuolar changes – limited to base or rete ridges. 
• Infiltrate around follicular epithelium may be present. 
• Vertical streaking of collagen bundles. 
ATROPHIC LP 
• Thinned out epidermis, though relative compact 
hyperkeratosis remains   
• Relatively few colloid bodies. Dermal fibrosis & loss of 
elastica, complete effacement of rete ridges.  
FOLLICULAR  LP85 
• Band-like infiltrate around infundibulum & isthmus. 
• Vacuolar changes of basal layer of outer root sheath.  
• Follicular Keratin plugging 
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• Interfollicular epidermis often spared. In well developed 
lesions, perifollicular fibrosis and epithelial atrophy – 
hourglass configuration 
MUCOSAL LP86  
• Thinned out epidermis 
• Both parakeratosis & orthokeratosis seen. Colloid bodies 
fewer 
• Bank-like infiltrate – more of plasma cells. Ulceration may 
develop  
LP PIGMENTOSUS 
• Prominent pigment incontinence that extends deeper into 
reticular dermis. Less prominent inflammatory infiltrate.  
BULLOUS LP 
• Infrabasal blister such that there is wide separation between 
epidermis and infiltrate. 
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LP ACTINICUS 
• Thinning of epidermis at the centre of lesion. More pigment 
incontinence in upper dermis. 
TWENTY NAIL DYSTROPHY 
• Typical LP involving nail matrix or  
• Spongiosis prominent as in cases associated with atopic 
dermatitis 
OLD INACTIVE LESIONS    
• Reduced inflammatory infiltrate, increased melanophages 
LICHEN PLANUS - LUPUS ERYTHEMATOSUS OVERLAP 
SYNDROME 
• Histology & IF may show features of LP or lupus 
predominantly or both may coexist.  
LICHEN PLANUS PEMPHIGOIDES87 
• Bulla from non-lesional skin shows subepidermal bulla with 
eosinophilic infiltrate similar to BP.  
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HISTOPATHOLOGICAL DIFFERENTIAL DIAGNOSIS 
 Lichen planus like keratoses 
Focal parakeratoses and adjacent solar lentigines in addition 
to typical histological picture of lichen planus Clinically , it 
is a solitary and non pruritic lesion. 
 Lichenoid drug eruptions 
         Focal parakeratoses with concomitant absence of granular 
layer Necrotic keratinocytes in the basal and spinous layer. Exocytosis of 
lymphocytes to the upper layers of epidermis Deeper inflammatory 
infiltrate with numerous eosinophils. 
 Lichenoid lupus erythematosus 
Atrophy of epidermis in addition to acanthosis. Absence of 
eosinophilia of keratinocytes in spinous layer. Superficial 
band like infiltrate with a superficial and deep    perivascular 
and periadnexal infiltrate. 
Presence of a thickened PAS positive basement membrane . 
Dermal mucin deposits 
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Direct Immunofluorescence- Linear or granular deposits of 
IgG and C3 predominate in lesional skin.  
In lichen planus, clusters of necrotic keratinocytes with 
absorbed immunoglobulins and complement are found. 
Langerhans cells are decreased in DLE & SLE whereas in 
lichen planus , they are increased. 
 Chronic GVHD 
Inflammatory infiltrate tends to be perivascular instead of 
band like. 
Langerhans cell number is reduced and nearly all 
intraepidermal lymphocytes are cytotoxic suppressor T- 
cells. 
 Lichen simplex chronicus 
     Longstanding hypertrophic lichen planus resembles LSC , 
but deeper sections of hypertrophic LP may still show areas of damage 
to the basal layer at the base of rete ridges. 
 Early SCC in situ 
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Both oral LP and SCC in situ may show hyperkeratosis and 
inflammatory infiltrate close to  the epidermis. 
But SCC in situ shows more atypical cells. 
 DLE 
           LPP of scalp in early phase resembles DLE. 
      DLE affects hair follicles as well as interfollicular epidermis. 
     DLE shows vacuolar degeneration of basal cells both in 
epidermis and in the hair follicles without disappearance of 
basal cells.It also shows a thickened  basement membrane 
and interfollicular, superficial and deep perivascular 
infiltrate. 
ELECRON MICROSCOPY 
Basal Keratinocytes together with their desmosomes and 
hemidesmosomes show degenerative changes. Necrotic keratinocytes88 
often still contain cell organelles (Melanosomes and Mitochondria) but 
only rarely contain nuclear material.  
The dermal infiltrate causes damage to the lamina densa 
(fragmentation) followed by reduplication & irregular  folding. Some of 
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the lymphocytes have hyperconvoluted nuclei & appear indistinguishable 
from Sezary cells. 
IMMUNOFLUORESCENCE 
Necrotic keratinocytes identified by IgM staining. IgG, IgA, C3 & 
fibrin89 may be also found. They are found in large numbers or arranged 
in clusters. Shaggy deposition of fibrinogen at DEJ. 
LPP – IgM and / or IgA, & rarely C3 at the level of infundibulum 
and isthmus. Shaggy deposition of fibrinogen around affected follicles. 
DEJ – negative for immunoreactants.  
LP Pemphigoides - IgG & C3 deposited linearly along the BMZ. 
C3 is localized to lamina lucida as in bullous pemphigoid    
IMMUNOHISTOCHEMISTRY 
¾ Infiltrating cells are predominantly T- lymphocytes with 
very few B lymphocytes. 
¾ More than 90% are activated T- lymphocytes expressing 
HLA-DR antigen and IL-2 receptor. 
¾ Both CD-4 + T-lymphocytes and CD-8 + T-lymphocytes 
participate in the immunological reaction . 
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¾ Immunophenotyping studies on T- lymphocytes have shown 
that the majority of clones were CD-8 + T- lymphocytes  
which displayed suppressor activity and expressed αβ-T cell 
receptor. 
¾ In the epidermis ,adjacent to the infiltrate ,basal 
keratinocytes express HLA-DR  surface antigens  and 
ICAM-1 ,both of which are implicated to enhance the 
interaction between lymphocytes and their epidermal targets 
resulting in keratinocyte destruction. 
¾ Langerhans cells are increased in the epidermis very early in 
the disease. 
ASSOCIATED CONDITIONS 
Auoimmune Disorders  
Alopecia areata, Vitiligo, Diabetes Mellitus, Morphoea, Lichen 
sclerosus, SLE, Dermatomyositis, Pemphigus, Myasthenia gravis, 
Primary biliary cirrhosis, Primary sclerosing cholangitis Autoimmune 
chronic active hepatitis, Ulcerative colitis.  
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Malignancies  
Bullous LP may be55 associated with lymphosarcoma, Castleman’s 
tumour, Carcinoma of stomach, Craniopharyngioma and Thymoma. 
Paraneoplastic lichen planus of skin & mucosa may be associated with 
cicatricial conjunctivitis. 
SYNDROMES ASSOCIATED WITH LICHEN PLANUS 
1. Graham Little Piccardi Lassueur90 Syndrome 
Patchy cicatricial alopecia of the scalp, patches of follicular 
spinous papules involving the trunk and patches of non-cicatricial 
alopecia in axilla and pubic area.  
2. Grinspan’s Syndrome91 
Association of oral lichen planus with vascular hypertension and 
diabetes mellitus.  
3. Jolly’s Syndrome 
Association or oral lichen planus with diabetes mellitus  
4. Lichen Planus / Lupus Erythematosus Overlap Syndrome 
Features of reticular white lesions in oral cavity, lichenoid lesions 
with chronic atrophic disseminated lupus erythematosus like lesions on 
 36
the head, neck and upper trunk. Extensive generalized lichen planus can 
be associated with subacute cutaneous disseminated lupus erythematosus. 
5. Vulvovaginal Gingival Syndrome Of Hewitt & Pelisse 
Desquamative vaginitis and gingivitis 
COMPLICATIONS  
a) Cicatricial alopecia 
b) permanant loss of nail – especially the variant with 
ulceration of soles 
c) Ulcerative, atrophic and plaque type  of oral lichen planus, 
vulval lesions and  hypertrophic lesions of skin have the 
potential of developing into  squamous cell carcinoma.  
d) Cicatricial conjunctivitis and lacrimal canalicular 
obstruction. 
DIAGNOSIS  
The appearance of the typical papule of lichen planus is usually 
sufficient to make the correct diagnosis. No specific abnormalities of 
laboratory analyses are seen in lichen planus. Histopathological and 
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immunofluorescent evaluation will confirm the diagnosis in cases 
presenting with atypical lesions. 
DIFFERENTIAL DIAGNOSIS 
a. Linear LP 
From nevus unis lateris, lichen striatus, linear psoriasis. 
b. Annular LP  
Granuloma annulare-no scales or Wickham striae in 
granuloma annulare. 
c. Hypertrophic LP –  
From lichen simplex chronicus, papular lichen amyloidosis 
and prurigo nodularis. 
d. Atrophic LP 
     From lichen sclerosus et atrophicus or guttate morphoea. 
e. LP pigmentosus    
     From erythema dyschromicum perstans. 
f. Follicular LP  
         May resemble lichen nitidus & lichen spinulosus  
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g. Cicatrical alopecia due to LP  
              From other causes of cicatricial alopecia like lupus 
erythematosus, cicatricial pemphigoid. 
h. Vesiculobullous LP  
From LP pemphigoides by direct and indirect 
immunofluorescence 
i. Guttate LP 
     From guttate psoriasis 
j. Palmoplantar LP 
May resemble Psoriasis vulgaris, warts, calluses, 
porokeratoses, hyperkeratotic eczema,  tinea or 
secondary syphilis.  
k. Lesions of tongue & buccal mucosa 
From leukoplakia. Gum margin lesions from gingivitis or 
chronic candidiasis. Palatal lesions from smoker’s patches, 
white sponge nevus.     
l. Lesions of female genitalia 
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     From lichen-sclerosus or leukoplakia. 
m. Twenty nail dystrophy can be caused by psoriasis and 
alopecia areata other than LP. 
n. Lichenoid eruptions are lichen planus like eruptions 
produced by GVHD,    drugs and exposure to colour film 
developers. They are differentiated by absence of oral 
lesions, psonasiform morphology, more itching, positive 
patch test to offending chemicals. Histologically they are 
differentiated           by  foci of parakeratosis, more of 
eosinophilic infiltrate and colloid bodies higher up in the 
epidermis. 
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TREATMENT 
CUTANEOUS LP 
a) Topical Steroids 
Potent – 0.05 % fluocinolone acetonide , 0.05 % clobetasol 
propionate.  
Under occlusion for localized and hypertrophic lichen planus 
b) Intralesional Steroids  
Triamcinolone acetonide – for oral , cutaneous and nail LP. 5 to 10 
mg \ml injection given every 4 weeks.Improvement in 3 to 4 months. 
Monitor for atrophy or hypopigmentation 
c) Systemic Steroids 
Prednisolone 30 to 80 mg per day for 4 to 6 weeks and then  
gradual tapering.                                   
LPP-oral steroids for 3 months. 
Long term chronic continuation of oral or injected steroids is 
contraindicated.               
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d) Oral Retinoids 
Tretinoin – 10 to 30 mg per day 
Acitretin – 30 mg per day 
e) Puva 
For generalized LP 
Both oral and topical PUVA can be used. 
f) Immunosuppressants 
Cyclosporine – 3 to 10 mg \kg \day-for recalcitrant cases and 
ulcerative LP  
Azathioprine 
Mycophenolate mofetil 
g) Other Drugs 
1. Dapsone 
2. Antimalarials 
3. Thalidomide 
4. Oral metronidazole 
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5. LMW Heparin 
6. Cyclophosphamide, Methotrexate, Phenytoin, Levamisole  
ORAL LP 
Good oral hygiene, replacement of amalgam with composite 
material  
1. Topical, intralesional and systemic steroids  
2. Topical Lidocaine gel or diphenhydramine to alleviate 
discomfort 
3. Vaginal or rectal suppositories of steroids 
4. Topical tretinoin or isotretinoin gel 
5. Oral retinoids 94 
6. Topical cyclosporine 
7. Topical tacrolimus and pimecrolimus 
8. Oral cyclosporine95 
9.  Others – Griseofulvin, itraconazole, hydroxychloroquine, 
thalidomide etc  can be tried. 
Malignant transformation of LP lesions can be treated with surgery 
and radiotherapy.  
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LICHEN PLANOPILARIS 
a. Short course of systemic steroids 
b. Intralesional and topical steroids 
c. Hydroxychloroquine 
d. Acitretin 
COURSE & PROGANOSIS  
85% lesions clear within 18 months. Mean duration of oral LP is 5 
yrs. The duration of disease is in the following order.  
Generalised < Cutaneous < Cutaneous + mucous membrane  
< mucosal < hypertrophic = lichen planopilaris  
Relapse occurs  in 15-20% cases71. Lichen planopilaris is the most 
chronic. Reticular oral LP has better prognosis than erosive disease. 
Itching disappears first, the papules flatten to be replaced by a 
corresponding area of post-inflammatory hyperpigmentation. 
 Malignant  transformation may occur in < 1% of persistent oral 
mucosal lesions on long term follow up & still rarely in hypertrophic LP 
or ulcerative LP of sole offeet.  
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AIMS OF THE STUDY 
1. To study the age and sex incidence of lichen planus 
2.  To study the incidence of various clinical types of LP 
3. To study the main symptomatology and various sites of 
distribution of lesions. 
4. To study the histopathological features 
5. To look for any known provocative factors by relevant 
history and  investigations. 
6. To look for  associated disorders if any .  
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MATERIALS AND METHODS 
100 patients of lichen planus were selected at random from the 
outpatients of Department of Dermatology, Madras Medical College 
during the period from April 2006 to April 2007. The cases were 
examined thoroughly Diagnosis was made by history, clinical 
examination & histopathological features. 
PROCEDURE  
History 
Enquiries were made with regard to symptoms, their duration, 
history of taking any drugs prior to lesion development and nature of 
occupation of the patient. Detailed personal history regarding other skin 
diseases, personal habits, exposure to STDs and possibility of emotional 
or physical stress prior to  the onset of lesions was recorded. History of 
Diabetes mellitus and hypertension were asked for. Family History of 
similar skin lesions was enquired. History of remissions and 
exacerbations with or without treatment was noted. 
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CLINICAL EXAMINATION 
Patients were examined under good day light and with a 
magnifying lens. The sites affected, types of changes in skin, mucous 
membranes and nails along with other associated disorders if any were 
made note of. General and systemic examination was done in all cases. 
Opinion regarding ENT & dental sepsis was sought from the relevant 
departments of Madras Medical College. 
EXCLUSION CRITERIA 
1)  Lichenoid eruptions 
2)  Patients already under treatment, outside or at our hospital, 
irrespective of whether this was the first episode or 
recurrence. 
LABORATORY INVESTIGATIONS 
Routine hematological investigation was done in all cases. Blood 
sugar, liver function test, Hepatitis B surface Antigen & Serology for 
STD was done in all cases. Urine & Motion  examination  was also done 
for all cases.  
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Biopsy of skin lesions was done, (the specimen preserved in 10% 
formalin) and sent for histopathological examination. Specimens were 
studied with H & E stains. 
Clinical photos were taken prior to commencement of 
investigations and treatment. 
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OBSERVATION 
1. AGE INCIDENCE 
The age incidence in the study group was as follows  
Age in Yrs No. of Cases 
0-9 3 
10-19 17 
20-29 11 
30-39 30 
40-49 15 
50-59 21 
60-69 2 
70-79 1 
The youngest case was 2 yrs old and the oldest 78 yrs old. 
2. SEX INCIDENCE 
Of the 100 cases, 55 were female & 45 male. No positive family 
history was found in any of the cases 
Sex No. of Cases 
Male 45 
Female 55 
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The main duration varied from 1 week to 4 yrs. History of 
recurrence was found in 5 cases.  
4. SYMPTOMATOLOGY 
Symptomatology No. Of Cases 
Itching (moderate to intense) 95 
Burning sensation on taking hot foods 25 
Itching was the predominant symptom in 95 cases excluding the 
cases with isolated mucosal or nail involvement. The severity of itching 
varied from moderate to intense. All the hypertrophic lesions were very 
itchy.All patients with oral mucosal involvement complained of burning 
sensation over the lesions on taking food.  
5. CLINICAL TYPES 
Clinical Type No. of Cases 
Classical 68 
Hypertrophic 12 
Linear 6 
Follicular 4 
Annular 3 
LP Pigmentosus 2 
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Clinical Type No. of Cases 
Oral Mucosa Alone 3 
Actinic 2 
Total 100 
• Oral mucosal involvement as the sole manifestation was 
seen in 3 cases. However, oral involvement associated with 
skin lesions was seen in 22 cases.  
• So, oral mucosa was involved in 25 cases.  
• Nail involvement was found in 10 cases.  
• Koebnerization was seen in 30 cases. 
6. ORAL INVOLVEMENT  
Oral Mucosal Involvement No. of Cases 
Oral involvement alone 3 
Oral involvement with skin lesions 22 
7. MORPHOLOGY & SITES OF DISTRIBUTION 
1. Lower limb was the predominant initial site of involvement 
seen in 60  cases. Papules and plaques were the commonest 
lesions seen. 
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2. Lesions were bilaterally symmetrical in most of the cases.  
3. Axilla & groin were involved predominantly in 3 cases 
although a few lesions were seen at classical sites. 
4. 25 cases showed generalized cutaneous involvement 
5. A few cases of generalized cutaneous involvement started as 
guttate lesions over trunk which gradually transformed into 
classical papules and plaques. 
6. 2 cases showed hyperpigmented patches & plaques 
surrounded by hypopigmented or violaceous ring  in children  
7. HYPERTROPHIC LP – Pigmented nodules & violaceous 
plaques were seen  over both shins and ankles, some 
showing central atrophy and depigmentation. No malignant 
transformation was seen in any of the  lesions.  
8. LINEAR LP – of the 6 cases, 3 showed linear unilateral 
lesions along either upper limb or lower limb. 2 cases had 
zosteriform lesions, one over thoracic & other over lumbar 
dermatome. 
 A 2 yr old female child had multiple linear LP lesions.  
9. FOLLICULAR LP - Of the 4 cases seen, 3 had cicatricial 
alopecia with one having cutaneous findings in addition. One 
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case showed follicular papules over trunk with no 
involvement of scalp. 
10. ANNULAR LP - All the three annular LP cases had isolated 
annular plaques over penis with no cutaneous or mucosal 
involvement 
11.  LP PIGMENTOSUS - Diffuse pigmented macules were 
seen symmetrically over the sun-exposed areas . 
 12.  ORAL MUCOSA - The sites involved were buccal mucosa, 
tongue, gums, palate & lips. 
The various types of lesions seen were violaceous papules, 
pigmented patches & plaques, reticulate networks. 
Tongue showed whitish plaques over dorsum and sides. 
Isolated lip involvement with skin lesions without 
involvement of oral mucosa was seen in a case. 
13.  GENITAL INVOLVEMENT - Violaceous papules and 
plaques were seen over pubic area, groin and labia majora as 
part  of generalized cutaneous involvement. 
14.  ACTINIC LP - Annular plaques were seen over forehead, 
temples, dorsum of hands. 
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15.  PALMOPLANTAR INVOLVEMENT - Usually occurs 
with cutaneous involvement. Grouped violaceous papules2 
plaques, pigmented scaly plaques, yellowish plaques & 
fissuring were the different types of lesions seen.  
Central aspect of palms & instep of soles were the most 
common sites involved with a few papules over adjoining 
wrist or ankle  
16.  NAILS - The commonest nail changes seen were 
longitudinal ridging followed by longitudinal melanonychia. 
Pterygium was seen in 1 case.  
8. HISTOPATHOLOGY 
Histopathological Finding No of Cases 
Hyperkeratosis 95 
Focal  Hypergranulosis 85 
Basal cell degeneration 100 
Pigment incontinence 100 
Band like inflammatory Infiltrate 90 
Saw-Toothing of Rete Ridges 80 
Colloid Bodies 40 
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1. Hyperkeratosis was observed in 95 cases and focal  
hypergranulosis in 85 cases . Basal cell degeneration and 
pigment incontinence was seen in all the cases. Band-like 
inflammatory infiltrate was seen in the upper dermis in 90 
cases. 
2. Saw - Toothing of rete ridges was seen in 80 cases 
3. Colloid bodies were identified in 40 cases. 
4. LPP – showed perifollicular infiltrate predominantly. 
5. LP pigmentosus – increased melanophages and pigment 
basal cell layer with sparse infiltrate in dermis was found.  
7. Histopathological findings were consistent with clinical 
diagnosis in all but 8 cases which had features  of lichenoid 
dermatitis. 
9. PROVOCATIVE FACTORS 
Provocative Factors No of Cases 
Dental (caries Tooth, Chr. Periodontitis 25 
ENT (pharyngitis, tonsillitis DNS) 15 
UTI 5 
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Provocative Factors No of Cases 
Entamoeba cysts 4 
Reduced Hb% 10 
Increased ESR 5 
Liver function test abnormalities  Nil 
HBsAg positivity Nil 
10. ASSOCIATED DISORDERS 
Associated Disorder No of Cases 
Hypertension 4 
Diabetes Mellitus 5 
Psoriasis 1 
Genital Vitiligo  1 
Tinea capitis 1 
Palmoplantar hyperhidrosis 1  
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DISCUSSION 
1. AGE INCIDENCE 
Maximum incidence of 66 % was found in the age group of  
30 to 59 years. The disease was uncommon in the extremes 
of age. This is  in contrast to  various Indian studies , 
showing 20-39 yrs29 and 20-4933 yrs as the commonest age 
groups affected . 
2. SEX INCIDENCE 
Slight female preponderance31 (F:M  - 1.2:1) was found in 
this study. 
3. SYMPTOMATOLOGY 
Moderate to severe itching31 was the predominant symptom 
in nearly all cases. Patients with oral lesions had burning 
sensation on intake of spicy foods. 
4.  No positive family history was found in any case similar to 
the study by  Garg et al. The duration  varied  from 1 week to 
4 years. 
 57
5.     History of recurrence was found in 5% cases as compared to 
19.3%     cases in a study by Bhatacharya et al. 
6. CLINICAL TYPES 
 Classical LP (66%) was the commonest followed by 
hypertrophic (2%) and linear LP (6 %). 
 The incidence of actinic LP was high in a few studies 33,97  
but in our study only 2 case of actinic LP were seen. 
The incidence of follicular LP & LP pigmentosus was less 
then 5% consistent with other studies 30,31. No case of 
bullous LP , ulcerative LP  or atrophic LP was seen in our 
study. No malignant transformation of hypertrophic lesions 
was found.  
 Cutaneous LP with mucosal involvement was seen in 22 
cases as in studies by Garg et al; Bhatacharya et al. Isolated 
oral mucosal involvement was seen in 3 cases as in study by 
Garg et al.  
 Nails were involved with cutaneous LP in 10 cases (Garg et 
al). which is consistent with literature. 
7. MORPHOLOGY AND DISTRIBUTION OF LESIONS 
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1. Papules and plaques were the predominant lesions 
found in 84 % similar to the study by Garg et al. 
 2. Lower limb was the initial site of involvement in 60 %  
 as in study by Kacchawa et al. 
 3. Generalised cutaneous involvement was seen in 25 % 
 cases. 
4. Koebnerization was found in 30 %. 
5. Hypertrophic, linear,follicular LP & LP pigmentosus 
showed classical  features as in the literature. 
6. 2 % of Zosteriform LP were described. 
7. Annular LP was confined to the penis 
8. Mucosal involvement – Buccal mucosa was the 
commonest site followed by lips 
 Pigmented patches & plaques were more common 
than reticulate networks.  
9. Among patients with palmoplantar involvement, 
central aspect of palms and instep of soles are the 
commonest sites involved. Violaceous & pigmented 
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plaques are commoner than yellowish plaques found 
in literature.  
11. Longitudinal ridging was the commonest nail finding 
followed by  longitudinal melanonychia consistent 
with literature. 
8.  HISTOPATHOLOGY  
 Histopathology was consistent with clinical diagnosis in all 
but 8 cases which showed features of lichenoid dermatitis. 
9.  PROVOCATIVE FACTORS 
1. ENT & Dental sepsis was found in 40% but, how far, 
this is provocative in causing LP needs to be 
determined. 
2. Anemia was found in 10 % & ESR raised in 5 %  
Garg et al study found all the blood investigations to 
be normal. 
 UTI was found in 5% and Amoebic cysts in 4%. These 
findings cannot be considered significant as the 
number of positive cases is low and similar findings  
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would be seen if we take 100 healthy subjects as 
controls. 
10.  ASSOCIATED DISORDERS 
Even though hypertension was seen in 4 % and Diabetes in 5 
%, this cannot be considered statistically significant. Studies 
by Kacchawa et al. & Garg etal show 1-3%association with 
Diabetes & hypertension.  
 Isolated cases of association with psoriasis, genital vitiligo, 
T.capitis, and palmoplantar hyperhidrosis pose no 
significance.  
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CONCLUSION 
1. 30-59  years is the commonest age group affected . 
2. Female preponderance in incidence was seen (1:2:1) 
3. No significant positive family history 
4. Mean duration – 1 week to 4 yrs. Recurrent episodes  in 5%. 
5. Classical LP was the commonest – 68 % 
6. Papules & plaques  were the commonest lesions. 
7. Lower limb was the initial site of involvement 
8. No malignant change was seen in hypertrophic lesions in this 
study 
9. Oral mucosa was involved in 25% 
10. Nails were involved in 10 % with longitudinal ridging being 
the commonest change. 
11. Histopathological findings correlated with clinical findings 
in 92%  of the cases.  
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12. No provocative factors could be identified statistically 
except for ENT and Dental sepsis which was found in 40 % 
of  the cases.The actual significance of this finding needs to 
be studied further . 
13. No significant association was found with any other 
metabolic or skin  disorder. 
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 PROFORMA 
Name :  
Age/Sex : Occupation : 
Address : OP. No. : 
PRESENTING COMPLAINTS : 
H/O PRESENT ILLNESS 
Onset : Sudden / insidious 
Skin lesions – Duration 
                 Progression 
                 Recurrence 
                 Remission & exacerbation 
Mucosal lesions – H/o dysphagia 
H/o pain or burning sensation on intake of hot or spicy food 
H/o itching- mild / severe  
H/o photosensitivity 
H/o Trauma 
H/o Drug intake 
H/o Focal sepsis 
H/o Emotional stress 
H/o dental fillings 
H/o contact with photodevelopers  
 H/o Koebnerization 
H/o sharp tooth 
H/o Jaundice 
H/o exposure to STD 
H/o alteration in bowel & bladder habits 
History  suggestive of autoimmune disease (thyroiditis / vitiligo) 
PAST HISTORY   -  H/o diabetes or Hypertension or 
Tuberculosis 
FAMILY HISTORY - Any other family  members having similar 
complaints 
TREATMENT HISTORY - H/o treatment in the past for similar 
complaints 
GENERAL EXAMINATION 
Anemia, Jaundice, cyanosis clubbing, pedal edema, lymphadenopathy 
Pulse Rate: CVS : 
BP:  RS : 
  Abdomen : 
  CNS : 
DERMATOLOGICAL EXAMINATION 
Sites affected : 
Morphological type : 
 Wickham’s striae : 
Koebnerization : 
Scalp :  
Palms & soles : 
Mucosa : oral & genital 
Nail : 
Associated skin lesions – Alopecia areata, vitiligo etc 
INVESTIGATIONS 
1. Complete Blood Count - TC 
  DC 
  Hb% 
  Platelet count 
2. Urine – Albumin, Sugar, Deposits 
3. Motion – Ova & cyst 
4. Blood VDRL 
5. Random Blood Sugar 
6. Liver Function test     
7. HBsAg 
8. Skin Biopsy 
